Search Results - "Khare Satyam, Leena"
-
1
Expression and heterodimerization of Type A and B Cholecystokinin Receptors in Gallbladder cancer
Published in Journal of clinical oncology (20-05-2019)“…Abstract only e15655 Background: Gallbladder cancer is the most common malignancy of the biliary tract and endemic in Northern India. The prognosis of…”
Get full text
Journal Article -
2
Abstract 1144: Orally bioavailable SMARCA2 degraders with exceptional selectivity and potency
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Background: SMARCA2 (BRM) and SMARCA4 (BRG1) are two mutually exclusive DNA-dependent ATPases of the SWI/SNF complex, which function in mobilizing…”
Get full text
Journal Article -
3
Abstract 1266: Discovery and preclinical evaluation of a novel covalent inhibitor of FABP5 for cancer therapy
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Dysregulated fatty acid metabolism is thought to be a hallmark of cancer, wherein fatty acids function both as an energy source and as signals for…”
Get full text
Journal Article -
4
Antibacterial spectrum of human omentum and differential expression of beta defensins
Published in Indian journal of gastroenterology (01-08-2019)“…Background Human β defensins (hBD1 and hBD2) are cationic, cysteine-rich peptides and form an integral part of the mammalian innate immune system. hBD1 is…”
Get full text
Journal Article -
5
A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population
Published in Journal of cancer research and clinical oncology (01-12-2016)“…Gallbladder cancer is a lethal malignancy of hepato-biliary system with high incidence in North India, especially along gangetic plain. The let-7 microRNAs…”
Get full text
Journal Article -
6
A let-7 microRNA binding site polymorphism in the KRAS 3′UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population
Published in Journal of cancer research and clinical oncology (01-12-2016)“…Purpose Gallbladder cancer is a lethal malignancy of hepato-biliary system with high incidence in North India, especially along gangetic plain. The let - 7…”
Get full text
Journal Article -
7
Abstract 3844: Anti-tumor efficacy of SMARCA degraders in pre-clinical models of cancer
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract SMARCA2/BRM and SMARCA4/BRG1 are the mutually exclusive DNA-dependent ATPases within the SWI/SNF complexes, which function in mobilizing nucleosomes…”
Get full text
Journal Article -
8
Abstract 5108: Potent small molecule compounds that selectively inhibit proliferation of ABC-DLBCL cell lines
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Diffuse large B cell lymphoma (DLBCL), which accounts for 25% of all lymphomas cases, has been classified into molecular subtypes including germinal…”
Get full text
Journal Article -
9
Abstract B164: Identification of a novel highly selective and orally bioavailable preclinical candidate for CDK7 covalent inhibition
Published in Molecular cancer therapeutics (01-01-2018)“…Abstract Background: Cyclin-dependent kinase 7 (CDK7) is an important constituent of the cellular transcriptional machinery, where it phosphorylates the…”
Get full text
Journal Article -
10
Abstract 3070: Potent and selective inhibition of CDK7 by novel covalent inhibitors
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Background: Phosphorylation of the RNA polymerase II (RNAPII) in C-terminal domain (CTD) by Cyclin-dependent kinase 7 (CDK7) is an important step in…”
Get full text
Journal Article -
11
Abstract 339: Identification of novel covalent inhibitors of K-Ras G12C that are efficacious in a xenograft model of NSCLC
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract KRAS is the frequently mutated isoform in RAS driven cancers. The G12C mutation is more predominantly associated with various tumor types over other…”
Get full text
Journal Article